FDA Drug recall D-1362-2014
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd…
- FDA Drug
- Class I
- terminated
- Published 2014-06-18
On 2014-06-18 the FDA classified a Class I recall of Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd… by Pharmakon Pharmaceuticals, citing superpotent Drug: Product contains twice the stated amount of midazolam.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1362-2014 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2014-03-26 |
| Published | 2014-06-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Pharmakon Pharmaceuticals |
| Distribution | IN |
Product
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.
Reason
Superpotent Drug: Product contains twice the stated amount of midazolam.
Identifiers
| code_info | Lot #: E1016227C, Exp. 4/21/2014; E0433735C, Exp. 4/20/2014 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1362-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.